Clinical Trial Detail

NCT ID NCT02610361
Title Study of the Safety and Pharmacokinetics of BGB-283 in Patients With Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors BeiGene
Indications

Advanced Solid Tumor

Therapies

BGB-283

Age Groups: adult

Additional content available in CKB BOOST